Date: Monday, 14 April 2008
Venue: Clark Center, Room E100 (Biodesign Collaboratory)

Session available:

• Session 1: 02:00pm - 02:30pm: Booked
• Session 2: 02:30pm - 03:00pm: Booked
• Session 3: 03:00pm - 03:30pm:
• Session 4: 03:30pm - 04:00pm:

Please email Christina Harvett with a short bio, to sign up.
__________________________________________________________

Kevin Wasserstein
Partner, Versant Ventures

Focus: Medical Device VC

Kevin Wasserstein specializes in investing and building medical device companies at Versant. His work with entrepreneurs spans the earliest seed or concept stage of development through the entire life cycle of the company. Kevin has more than fifteen years of venture capital and operating experience in medical device and high technology companies.

Prior to joining Versant in 2002, Kevin served in a variety of marketing and business development roles at Guidant Corporation, including acting as the Director of Marketing in Guidant's Cardiac Surgery Group, managing market/product development and launch initiatives. Kevin also served as Senior Global Product Manager in Guidant's Peripheral and Carotid Group, during which he developed and launched several first-generation stent and embolic protection devices. Previously, in Guidant's Compass Business Development Group, Kevin was involved in acquisition, licensing and investment activities with both private and public medical device companies, and in formulating corporate strategies to develop innovative medical technologies.

In addition, Kevin's operational experience includes business development at Heartstream, and engineering design and engineering management responsibilities at Hughes Aircraft Company. Kevin serves, or has served, in a variety of board or advisory roles with companies which include: Acclarent, Cellutions, LipoSonix, NDO Surgical, NeoGuide Systems, Rox Medical, Second Sight Medical, St. Francis Medical (sold) and The Innovation Factory. Kevin holds both Bachelor's and Master's degrees in Mechanical Engineering, as well as an MBA, all from Stanford University.